Lifecore Biomedical Inc expected to post a loss of 4 cents a share - Earnings Preview

Lifecore Biomedical

30/12/2022 11:09

* Lifecore Biomedical Inc  LFCR.OQ   LFCR.O  is expected
to show a
rise in quarterly revenue when it reports  results on January 3
(estimated). 
    * The Chaska Minnesota-based  company is expected to report 
a
7.3% increase in revenue to $46.602 million from $43.45 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lifecore Biomedical
Inc
is for a loss of 4 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lifecore
Biomedical Inc is $13.5​, above​ its last closing price
of $6.91. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Aug. 31 2022  -0.13       -0.13      -0.32     Missed  -137
 May. 31 2022              -0.01      -0.01     Met     25
 Feb. 28 2022  -0.01       0.00       -0.08     Missed  -1,500
                                                        ​
 Nov. 30 2021  -0.04       -0.04      0.05      Beat    225
 ​​Aug.        -0.12       -0.12      -0.23     Missed  -98.3
 31 2021                                                
 May. 31 2021  -0.01       -0.01      0.07      Beat    975​
 Feb. 28 2021  0.03        0.02       -0.09     Missed  -475
 Nov. 30 2020  0.03        0.01       0.02      Beat    100
 This summary was machine generated December 30 at 11:09 GMT. 
All figures in US dollars  unless otherwise stated